MENU
+Compare
ATAI
Stock ticker: NASDAQ
AS OF
Jun 6, 11:40 AM (EDT)
Price
$2.48
Change
-$0.01 (-0.40%)
Capitalization
494.83M

ATAI ATAI Life Sciences NV Forecast, Technical & Fundamental Analysis

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes... Show more

ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATAI with price predictions
Jun 05, 2025

ATAI sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ATAI moved above the 200-day moving average on May 20, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 15, 2025. You may want to consider a long position or call options on ATAI as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ATAI just turned positive on May 15, 2025. Looking at past instances where ATAI's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

ATAI moved above its 50-day moving average on May 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ATAI crossed bullishly above the 50-day moving average on May 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATAI advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 101 cases where ATAI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

ATAI broke above its upper Bollinger Band on May 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATAI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.262) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). ATAI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (217.391) is also within normal values, averaging (263.647).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATAI is expected to report earnings to rise 10.13% to -16 cents per share on August 18

ATAI Life Sciences NV ATAI Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.09
Q3'24
Est.
$-0.16
Q2'24
Missed
by $0.20
The last earnings report on May 14 showed earnings per share of -15 cents, beating the estimate of -15 cents. With 292.85K shares outstanding, the current market capitalization sits at 494.83M.
A.I.Advisor
published Dividends

ATAI paid dividends on August 24, 2018

ATAI Life Sciences NV ATAI Stock Dividends
А annual dividend of $1.50 per share was paid with a record date of August 24, 2018, and an ex-dividend date of August 27, 2018. Read more...
A.I. Advisor
published General Information

General Information

a provider of computer-based testing services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
Wallstrasse 16
Phone
+49 8921539035
Employees
88
Web
https://www.atai.life
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIAGX17.19N/A
N/A
Brown Advisory Growth Equity Inv
CBBIX6.48N/A
N/A
AB Relative Value I
RMBKX45.78N/A
N/A
RMB Mendon Financial Services A
MSJCX16.53N/A
N/A
Morgan Stanley Global Endurance C
CSRIX49.35-0.01
-0.02%
Cohen & Steers Instl Realty Shares

ATAI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+0.40%
MNMD - ATAI
54%
Loosely correlated
+0.52%
ABCL - ATAI
47%
Loosely correlated
-2.27%
RXRX - ATAI
47%
Loosely correlated
-7.13%
CYBN - ATAI
46%
Loosely correlated
+2.80%
CRSP - ATAI
46%
Loosely correlated
+1.37%
More